Dopamine receptor study offers hope for improved treatments with fewer side effects

September 4, 2018, Columbia University
Ball-and-stick model of the dopamine molecule, a neurotransmitter that affects the brain's reward and pleasure centers. Credit: Jynto/Wikipedia

New work from researchers at Columbia University Vagelos College of Physicians and Surgeons sheds light on how dopamine receptors signal within cells, opening the door for more targeted—and more tolerable—therapeutics to treat an array of neuropsychiatric disorders.

The study's findings have been published in the journal Molecular Psychiatry.

The central nervous system's play a critical role in a variety of neural processes, including motor control, learning and memory, and reward. The focus of this study, the dopamine D2 receptor (D2R), is an important target in the treatment of disorders such as schizophrenia and Parkinson's disease. Drugs used to treat these conditions either block or activate these receptors to address dysfunctional receptor signaling. Antipsychotic drugs that target D2Rs, however, can have many unpleasant side effects, including weight gain, involuntary movements, and decreased motivation.

Scientists know that D2Rs send signals through two main pathways within cells—either by activating G proteins or by G-protein independent arrestin-signaling. Recent studies of opioid —targeted for pain relief—suggest that it may be possible to maintain the therapeutic effects while avoiding negative side effects, such as respiratory depression, by selectively activating the G protein signaling . "We asked whether these signaling pathways might also lead to different behavioral effects at the D2R, and whether this might provide a new approach to improved with fewer side effects," says Dr. Jonathan Javitch, Lieber Professor of Experimental Therapeutics in Psychiatry and professor of pharmacology at Columbia University Vagelos College of Physicians and Surgeons.

In order to determine whether the two pathways regulate different behaviors, the researchers examined mice that were engineered to carry a mutated D2R that only facilitated the arrestin pathway. In these mice, the mutant dopamine receptor restored motor function just as the non-mutant form of the receptor does, indicating that arrestin recruitment can enhance motor function on its own. In contrast, motivation was enhanced only by wild-type D2R. "This finding was quite exciting as it indicates that the activational component of motivation that enhances locomotion is regulated by a different intracellular mechanism than the reward driven directional component," says Dr. Christoph Kellendonk, associate professor of pharmacology (in Psychiatry) at Columbia University Vagelos College of Physicians and Surgeons. "For the former, arrestin signaling is sufficient whereas the latter requires activation of G-proteins."

"These results offer the exciting possibility that therapeutic approaches targeting specific D2R-mediated signaling pathways could not only treat psychosis, but also avoid some of the adverse side effects experienced by patients taking the existing, less targeted medications," says Javitch.

The study is titled "Arrestin recruitment to dopamine D2 receptor mediates locomotion but not incentive motivation."

Explore further: Heart disease severity may depend on nitric oxide levels

More information: Prashant Donthamsetti et al, Arrestin recruitment to dopamine D2 receptor mediates locomotion but not incentive motivation, Molecular Psychiatry (2018). DOI: 10.1038/s41380-018-0212-4

Related Stories

Heart disease severity may depend on nitric oxide levels

May 14, 2018
The most common heart medications may get an assist from nitric oxide circulating in the body, according to a new study out of Case Western Reserve University School of Medicine. Researchers showed that nitric oxide may help ...

New discovery sheds light on proteins critical in mood and behavior disorders

August 8, 2018
Researchers at Columbia University Irving Medical Center (CUIMC) have found new evidence of how certain transport proteins are working at the molecular level, paving the way for new, improved drugs to treat psychiatric disorders.

Looking beyond the drug receptor for clues to drug effectiveness

August 25, 2008
Antipsychotic drugs that are widely used to treat schizophrenia and other problems may not work as scientists have assumed, according to findings from Duke University Medical Center researchers that could lead to changes ...

Investigators eye new target for treating movement disorders

January 19, 2018
Blocking a nerve-cell receptor in part of the brain that coordinates movement could improve the treatment of Parkinson's disease, dyskinesia and other movement disorders, researchers at Vanderbilt University have reported.

Synthetic receptors can rewire cell functions and minimize side-effects

June 18, 2018
One of the challenges of modern pharmacology is specificity. Despite therapeutic effects, drugs can often have side effects. The biological basis for this has to do with the proteins and receptors that the drug targets and ...

Dopamine receptor blockade seen as cause for antipsychotic drug side-effects

July 6, 2016
Since their development in the 1950s, antipsychotic drugs have been widely used to treat psychoses and neuropsychiatric disorders like schizophrenia. A debilitating side-effect of these drugs called parkinsonism limits their ...

Recommended for you

College students choose smartphones over food

November 16, 2018
University at Buffalo researchers have found that college students prefer food deprivation over smartphone deprivation, according to results from a paper in Addictive Behaviors.

Social media is affecting the way we view our bodies—and not in a good way

November 15, 2018
Young women who actively engage with social media images of friends who they think are more attractive than themselves report feeling worse about their own appearance afterward, a York University study shows.

Study finds mindfulness apps can improve mental health

November 15, 2018
A University of Otago study has found that using mindfulness meditation applications (apps) on phones is associated with improvements in people's mental health.

New research has revealed we are actually better at remembering names than faces

November 14, 2018
With the Christmas party season fast approaching, there will be plenty of opportunity to re-live the familiar, and excruciatingly-awkward, social situation of not being able to remember an acquaintance's name.

Older adults' abstract reasoning ability predicts depressive symptoms over time

November 14, 2018
Age-related declines in abstract reasoning ability predict increasing depressive symptoms in subsequent years, according to data from a longitudinal study of older adults in Scotland. The research is published in Psychological ...

The illusion of multitasking boosts performance

November 13, 2018
Our ability to do things well suffers when we try to complete several tasks at once, but a series of experiments suggests that merely believing that we're multitasking may boost our performance by making us more engaged in ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.